Recalls / —
—#143008
Product
IMMULITE 1000 Estradiol Test Code E2 Catalog Number: LKE21, LKE21(D), LKE25 SMN: 10381132, 10702832, 10381142 Product Usage: For in vitro diagnostic use with the IMMULITE and IMMULITE 1000 Analyzers - for the quantitative measurement of estradiol in serum, as an aid in the diagnosis and treatment of various hormonal sexual disorders
- FDA product code
- CHP — Radioimmunoassay, Estradiol
- Device class
- Class 1
- Medical specialty
- Clinical Chemistry
- 510(k) numbers
- K932926
- Affected lot / code info
- All lots
Why it was recalled
The drug fulvestrant (Faslodex) may cause falsely elevated estradiol results.
Root cause (FDA determination)
Device Design
Action the firm took
Siemens issued an Urgent Medical Device Correction (UMDC) to affected Siemens Healthcare Diagnostics customers in the United States on January 13, 2016 to be delivered to customers on January 14, 2016 via Federal Express. An Urgent Field Safety Notice (UFSN) was sent out for distribution to all customers outside the United States on January 13, 2016. The letters identified affected product, problem and the actions to be taken. Customers may continue to use the estradiol assays to report patient results however, the assays should not be used for patients being treated with fulvestrant. Customers where instructed to complete and return the Correction Effectiveness Check attached. For questions contact your Siemens Customer Care Center or your local Siemens technical support representative.
Recalling firm
- Firm
- Siemens Healthcare Diagnostics, Inc
- Address
- 333 Coney St, East Walpole, Massachusetts 02032-1516
Distribution
- Distribution pattern
- Worldwide Distribution US Nationwide , AR, AU, AU, BD, BO, BR, CA, CH, CL, CN, CO, DO, EC, EG, HK, ID, IE, IL, IN, JP, KR, LK, LY, MX, MY, NI, NP, NZ, PE, PH, PY, SA, SG, SV, TH, TW, UY, VE, VN, and ZA.
Timeline
- Recall initiated
- 2016-01-13
- Terminated
- 2018-01-08
- Status
- —
Source: openFDA Device Recall endpoint. Recall record ID #143008. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.